Literature DB >> 25223556

Cancer therapy: retinoblastoma--chemotherapy increases the risk of secondary cancer.

Alessia Errico.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25223556     DOI: 10.1038/nrclinonc.2014.155

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.

Authors:  Jeannette R Wong; Lindsay M Morton; Margaret A Tucker; David H Abramson; Johanna M Seddon; Joshua N Sampson; Ruth A Kleinerman
Journal:  J Clin Oncol       Date:  2014-09-02       Impact factor: 44.544

  1 in total
  7 in total

1.  Thrombospondin-1 might be a therapeutic target to suppress RB cells by regulating the DNA double-strand breaks repair.

Authors:  Pei Chen; Na Yu; Zhang Zhang; Ping Zhang; Ying Yang; Nandan Wu; Lijun Xu; Jing Zhang; Jian Ge; Keming Yu; Jing Zhuang
Journal:  Oncotarget       Date:  2016-02-02

2.  Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis.

Authors:  Zhongrui Li; Lan Zhang; Dongrui Liu; Zhanghui Yang; Di Xuan; Yi Zhang
Journal:  Cell Death Discov       Date:  2022-01-10

3.  SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling.

Authors:  Alan Jiang; Weiqi Wu; Caixia Xu; Longbing Mao; Sha Ao; Huifeng Guo; Xiantao Sun; Jing Tao; Yi Sang; Guofu Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

4.  Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis.

Authors:  Yanhua Jiang; Fan Xiao; Lin Wang; Ting Wang; Linlin Chen
Journal:  Mol Cell Biochem       Date:  2020-08-25       Impact factor: 3.396

5.  Identification of co‑expression modules and hub genes of retinoblastoma via co‑expression analysis and protein‑protein interaction networks.

Authors:  Yukun Mao; Qingbin Nie; Yang Yang; Gengsheng Mao
Journal:  Mol Med Rep       Date:  2020-05-27       Impact factor: 2.952

6.  MiR-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway.

Authors:  Yujun Liao; Xiaolong Yin; Yan Deng; Xiaowei Peng
Journal:  Biosci Rep       Date:  2018-11-30       Impact factor: 3.840

7.  Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.

Authors:  Xiaowen Sun; Hui Shen; Shubin Liu; Jing Gao; Shuyan Zhang
Journal:  Int J Mol Med       Date:  2020-03-20       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.